Back from ASH 2025, Dr Suchitra Sundaram reports on notable frontline CLL data. Time‑limited pirtobrutinib combined with venetoclax and obinutuzumab produced high rates of undetectable minimal ...
Clonal B-cell–mediated hypogammaglobulinemia is common (up to 85%) and can coexist with qualitative immune defects that blunt vaccine responses and protection against encapsulated bacteria. T-cell ...
If someone says they solved a Rubik’s Cube in under half a second, you’d probably think they’re joking. That’s less time than it takes to blink, sneeze, or even realize you’re holding the puzzle.But ...
T-cell Acute Lymphoblastic Leukaemia (T-ALL) is a high-risk hematological disease constituting ~20% of acute leukemias. To date, the only subtype recognized by the World Health Organization’s ...
Inflammation is a natural bodily process. It’s a defense system tool used by the body to fight off infections and heal injuries. Think of a time when you’ve cut a finger, for example, or scraped an ...
Table 1 Recommended modifications of diagnosis and conventional treatment for children and adolescents with acute lymphoblastic leukemia, based on available resources. The French-American-British ...
For patients with acute myeloid leukemia (AML) who are 75 years of age or older or who are ineligible for intensive induction chemotherapy, azacitidine or decitabine plus venetoclax is the standard of ...
Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics. Renée previously worked as senior pet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results